234 related articles for article (PubMed ID: 24037032)
1. Protein disulfide isomerase P5-immunopositive inclusions in patients with Alzheimer's disease.
Honjo Y; Horibe T; Torisawa A; Ito H; Nakanishi A; Mori H; Komiya T; Takahashi R; Kawakami K
J Alzheimers Dis; 2014; 38(3):601-9. PubMed ID: 24037032
[TBL] [Abstract][Full Text] [Related]
2. Protein disulfide isomerase-immunopositive inclusions in patients with Alzheimer disease.
Honjo Y; Ito H; Horibe T; Takahashi R; Kawakami K
Brain Res; 2010 Aug; 1349():90-6. PubMed ID: 20550946
[TBL] [Abstract][Full Text] [Related]
3. Decreased levels of PDI and P5 in oligodendrocytes in Alzheimer's disease.
Honjo Y; Ayaki T; Tomiyama T; Horibe T; Ito H; Mori H; Takahashi R; Kawakami K
Neuropathology; 2017 Dec; 37(6):495-501. PubMed ID: 28731225
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
Uehara T; Nakamura T; Yao D; Shi ZQ; Gu Z; Ma Y; Masliah E; Nomura Y; Lipton SA
Nature; 2006 May; 441(7092):513-7. PubMed ID: 16724068
[TBL] [Abstract][Full Text] [Related]
5. Derlin-1-immunopositive inclusions in patients with Alzheimer's disease.
Honjo Y; Ito H; Horibe T; Shimada H; Nakanishi A; Mori H; Takahashi R; Kawakami K
Neuroreport; 2012 Jul; 23(10):611-5. PubMed ID: 22627700
[TBL] [Abstract][Full Text] [Related]
6. Protein disulfide isomerase immunopositive glial cytoplasmic inclusions in patients with multiple system atrophy.
Honjo Y; Ito H; Horibe T; Takahashi R; Kawakami K
Int J Neurosci; 2011 Oct; 121(10):543-50. PubMed ID: 21689057
[TBL] [Abstract][Full Text] [Related]
7. Glutathione depletion results in S-nitrosylation of protein disulfide isomerase in neuroblastoma cells.
Ono S; Ogura J; Sugiura H; Yamauchi M; Tanaka A; Sato T; Maekawa M; Yamaguchi H; Mano N
Life Sci; 2023 Mar; 316():121442. PubMed ID: 36708988
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
9. S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis.
Chen X; Zhang X; Li C; Guan T; Shang H; Cui L; Li XM; Kong J
J Neurochem; 2013 Jan; 124(1):45-58. PubMed ID: 23043510
[TBL] [Abstract][Full Text] [Related]
10. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
11. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
[TBL] [Abstract][Full Text] [Related]
13. Phase Separation and Cytotoxicity of Tau are Modulated by Protein Disulfide Isomerase and S-nitrosylation of this Molecular Chaperone.
Wang K; Liu JQ; Zhong T; Liu XL; Zeng Y; Qiao X; Xie T; Chen Y; Gao YY; Tang B; Li J; Zhou J; Pang DW; Chen J; Chen C; Liang Y
J Mol Biol; 2020 Mar; 432(7):2141-2163. PubMed ID: 32087196
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
15. Rescue of ER oxidoreductase function through polyphenolic phytochemical intervention: implications for subcellular traffic and neurodegenerative disorders.
Pal R; Cristan EA; Schnittker K; Narayan M
Biochem Biophys Res Commun; 2010 Feb; 392(4):567-71. PubMed ID: 20097158
[TBL] [Abstract][Full Text] [Related]
16. Glucose-induced oxidative stress leads to in S-nitrosylation of protein disulfide isomerase in neuroblastoma cells.
Ogura J; Sugiura H; Tanaka A; Ono S; Sato T; Sato T; Maekawa M; Yamaguchi H; Mano N
Biochim Biophys Acta Gen Subj; 2021 Nov; 1865(11):129998. PubMed ID: 34474117
[TBL] [Abstract][Full Text] [Related]
17. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
Gómez-Ramos P; Morán MA
Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
